Symptom burden in heart failure: assessment, impact on outcomes, and management

Heart Failure Reviews

Volumn 22, Issue 1, 2017, Pages 25-39

  Alpert, Craig M ^a   Smith, Michael A ^b,c   Hummel, Scott L ^a,d   Hummel, Ellen K ^b,c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Heart failure; Palliative care; Quality of life; Supportive care; Symptoms

Indexed keywords

CITALOPRAM; DOCUSATE SODIUM; DRONABINOL; ESCITALOPRAM; FENTANYL; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; HYDROMORPHONE; MACROGOL; MAGNESIUM HYDROXIDE; MELATONIN; METOCLOPRAMIDE; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; OXYCODONE; PARACETAMOL; PAROXETINE; PROCHLORPERAZINE; PROMETHAZINE; SERTRALINE; TRAMADOL; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ANGINA PECTORIS; ANOREXIA; BEHAVIOR CHANGE; COGNITIVE BEHAVIORAL THERAPY; CONSTIPATION; DEPRESSION; DYSPNEA; EDEMA; FATIGUE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART FAILURE; HOSPITALIZATION; HUMAN; HYPONATREMIA; MUSCULOSKELETAL PAIN; NAUSEA; NEUROPATHIC PAIN; NOCICEPTIVE PAIN; OXYGEN THERAPY; PSYCHOTHERAPY; QT PROLONGATION; QUALITY OF LIFE; REVIEW; SLEEP DISORDER; DISEASE EXACERBATION; DISEASE MANAGEMENT; EVIDENCE BASED MEDICINE; GLOBAL HEALTH; PALLIATIVE THERAPY; PREVALENCE; PROCEDURES; SELF CARE; SURVIVAL RATE; TIME FACTOR; TRENDS;

DISEASE MANAGEMENT; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; GLOBAL HEALTH; HEART FAILURE; HUMANS; PALLIATIVE CARE; PREVALENCE; SELF CARE; SURVIVAL RATE; TIME FACTORS;

EID: 84984887764     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-016-9581-4     Document Type: Review

References (201)

1. Heidenreich PA, Albert NM, Allen LA et al (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6(3):606–619
2. Yancy CW, Jessup M, Bozkurt B et al (2013) ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol 62(16):e147–e239
3. Singer PA, Martin DK, Kelner M (1999) Quality end-of-life care: patients’ perspectives. JAMA 281:163–168
4. Stanek EJ, Oates MB, McGhan WF, Denofrio D, Loh E (2000) Preferences for treatment outcomes in patients with heart failure: symptoms versus survival. J Card Fail 6:225–232
5. Stevenson LW, Hellkamp AS, Leier CV et al (2008) Changing preferences for survival after hospitalization with advanced heart failure. J Am Coll Cardiol 52:1702–1708
6. Jalowiec A, Grady KL, White-Williams C (1994) Stressors in patients awaiting a heart transplant. Behav Med 19:145–154
7. Chochinov HM, Tataryn D, Clinch JJ, Dudgeon D (1999) Will to live in the terminally ill. Lancet 354:816–819
8. Steinhauser KE, Clipp EC, McNeilly M, Christakis NA, McIntyre LM, Tulsky JA (2000) In search of a good death: observations of patients, families, and providers. Ann Intern Med 132:825–832
9. Singer AE, Meeker D, Teno JM, Lynn J, Lunney JR, Lorenz KA (2015) Symptom trends in the last year of life from 1998 to 2010: a cohort study. Ann Intern Med 162:175–183
10. Qaseem A, Snow V, Shekelle P et al (2008) Evidence-based interventions to improve the palliative care of pain, dyspnea, and depression at the end of life: a clinical practice guideline from the American College of Physicians. Ann Intern Med 148:141–146
11. Brannstrom M, Hagglund L, Furst CJ, Boman K (2012) Unequal care for dying patients in Sweden: a comparative registry study of deaths from heart disease and cancer. Eur J Cardiovasc Nurs 11:454–459
12. Brannstrom M, Boman K (2014) Effects of person-centred and integrated chronic heart failure and palliative home care. PREFER: a randomized controlled study. Eur J Heart Fail 16:1142–1151
13. Setoguchi S, Glynn RJ, Stedman M, Flavell CM, Levin R, Stevenson LW (2010) Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer. Am Heart J 160:139–144
14. Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273:59–65
15. Hinton JM (1963) The physical and mental distress of the dying. Q J Med 32:1–21
16. Evangelista LS, Lombardo D, Malik S, Ballard-Hernandez J, Motie M, Liao S (2012) Examining the effects of an outpatient palliative care consultation on symptom burden, depression, and quality of life in patients with symptomatic heart failure. J Card Fail 18:894–899
17. Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manag 31:58–69
18. Bekelman DB, Rumsfeld JS, Havranek EP et al (2009) Symptom burden, depression, and spiritual well-being: a comparison of heart failure and advanced cancer patients. J Gen Intern Med 24:592–598
19. Nordgren L, Sorensen S (2003) Symptoms experienced in the last six months of life in patients with end-stage heart failure. Eur J Cardiovasc Nurs 2:213–217
20. Lokker ME, Gwyther L, Riley JP, van Zuylen L, van der Heide A, Harding R (2016) The prevalence and associated distress of physical and psychological symptoms in patients with advanced heart failure attending a South African Medical Center. J Cardiovasc Nurs 31(4):313–322
21. Bekelman DB, Havranek EP, Becker DM et al (2007) Symptoms, depression, and quality of life in patients with heart failure. J Card Fail 13:643–648
22. Zambroski CH, Moser DK, Bhat G, Ziegler C (2005) Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs 4:198–206
23. Lewis EF, Lamas GA, O’Meara E et al (2007) Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail 9:83–91
24. Kugler C, Malehsa D, Tegtbur U et al (2011) Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study. J Heart Lung Transplant 30:204–210
25. Simon JR (2008) Case study. “Doctor, will you turn off my LVAD?” Commentary. Hastings Cent Rep 38:14–15
26. Casida JM, Parker J (2012) A preliminary investigation of symptom pattern and prevalence before and up to 6 months after implantation of a left ventricular assist device. J Artif Organs 15:211–214
27. Grady KL, Meyer PM, Dressler D et al (2004) Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. Ann Thorac Surg 77:1321–1327
28. Jalowiec A, Grady KL, White-Williams C et al (1997) Symptom distress three months after heart transplantation. J Heart Lung Transplant 16:604–614
29. Rosenblum DS, Rosen ML, Pine ZM, Rosen SH, Borg-Stein J (1993) Health status and quality of life following cardiac transplantation. Arch Phys Med Rehabil 74:490–493
30. Gadoud A, Jenkins SM, Hogg KJ (2013) Palliative care for people with heart failure: summary of current evidence and future direction. Palliat Med 27:822–828
31. Goodlin SJ (2009) Palliative care in congestive heart failure. J Am Coll Cardiol 54:386–396
32. Jaarsma T, Beattie JM, Ryder M et al (2009) Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 11:433–443
33. Walke LM, Byers AL, Tinetti ME, Dubin JA, McCorkle R, Fried TR (2007) Range and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failure. Arch Intern Med 167:2503–2508
34. Barnes S, Gott M, Payne S et al (2006) Prevalence of symptoms in a community-based sample of heart failure patients. J Pain Symptom Manag 32:208–216
35. Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS (2000) The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 48:S101–S109
36. Kirkpatrick JN, Guger CJ, Arnsdorf MF, Fedson SE (2007) Advance directives in the cardiac care unit. Am Heart J 154:477–481
37. Chen-Scarabelli C, Saravolatz L, Hirsh B, Agrawal P, Scarabelli TM (2015) Dilemmas in end-stage heart failure. J Geriatr Cardiol 12:57–65
38. Lemond L, Allen LA (2011) Palliative care and hospice in advanced heart failure. Prog Cardiovasc Dis 54:168–178
39. Malik FA, Gysels M, Higginson IJ (2013) Living with breathlessness: a survey of caregivers of breathless patients with lung cancer or heart failure. Palliat Med 27:647–656
40. Whittingham K, Barnes S, Gardiner C (2013) Tools to measure quality of life and carer burden in informal carers of heart failure patients: a narrative review. Palliat Med 27:596–607
41. Lee CS, Gelow JM, Denfeld QE et al (2014) Physical and psychological symptom profiling and event-free survival in adults with moderate to advanced heart failure. J Cardiovasc Nurs 29:315–323
42. Ekman I, Cleland JG, Swedberg K, Charlesworth A, Metra M, Poole-Wilson PA (2005) Symptoms in patients with heart failure are prognostic predictors: insights from COMET. J Card Fail 11:288–292
43. Patel H, Shafazand M, Schaufelberger M, Ekman I (2007) Reasons for seeking acute care in chronic heart failure. Eur J Heart Fail 9:702–708
44. Evangelista LS, Sackett E, Dracup K (2009) Pain and heart failure: unrecognized and untreated. Eur J Cardiovasc Nurs 8:169–173
45. Goebel JR, Doering LV, Shugarman LR et al (2009) Heart failure: the hidden problem of pain. J Pain Symptom Manag 38:698–707
46. Goode KM, Nabb S, Cleland JG, Clark AL (2008) A comparison of patient and physician-rated New York Heart Association class in a community-based heart failure clinic. J Card Fail 14:379–387
47. Ekman I, Cleland JG, Andersson B, Swedberg K (2005) Exploring symptoms in chronic heart failure. Eur J Heart Fail 7:699–703
48. Thomas JM, O’Leary JR, Fried TR (2009) Understanding their options: determinants of hospice discussion for older persons with advanced illness. J Gen Intern Med 24:923–928
49. Lynn J, Harrell F Jr, Cohn F, Wagner D, Connors AF Jr (1997) Prognoses of seriously ill hospitalized patients on the days before death: implications for patient care and public policy. New Horiz 5:56–61
50. Low J, Pattenden J, Candy B, Beattie JM, Jones L (2011) Palliative care in advanced heart failure: an international review of the perspectives of recipients and health professionals on care provision. J Card Fail 17:231–252
51. Friedman MM (1997) Older adults’ symptoms and their duration before hospitalization for heart failure. Heart Lung 26:169–176
52. Jurgens CY, Shurpin KM, Gumersell KA (2010) Challenges and strategies for heart failure symptom management in older adults. J Gerontol Nurs 36:24–33
53. Rogers A, Addington-Hall JM, McCoy AS et al (2002) A qualitative study of chronic heart failure patients’ understanding of their symptoms and drug therapy. Eur J Heart Fail 4:283–287
54. Bennett SJ, Cordes DK, Westmoreland G, Castro R, Donnelly E (2000) Self-care strategies for symptom management in patients with chronic heart failure. Nurs Res 49:139–145
55. Blinderman CD, Billings JA (2015) Comfort care for patients dying in the hospital. N Engl J Med 373:2549–2561
56. Ezekowitz JA, Thai V, Hodnefield TS, Sanderson L, Cujec B (2011) The correlation of standard heart failure assessment and palliative care questionnaires in a multidisciplinary heart failure clinic. J Pain Symptom Manag 42:379–387
57. Opasich C, Gualco A (2007) The complex symptom burden of the aged heart failure population. Curr Opin Support Palliat Care 1:255–259
58. Heidenreich PA, Spertus JA, Jones PG et al (2006) Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol 47:752–756
59. Song EK, Moser DK, Rayens MK, Lennie TA (2010) Symptom clusters predict event-free survival in patients with heart failure. J Cardiovasc Nurs 25:284–291
60. Melzack R (1990) The tragedy of needless pain. Sci Am 262:27–33
61. Blinderman CD, Homel P, Billings JA, Portenoy RK, Tennstedt SL (2008) Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manag 35:594–603
62. Goebel JR, Doering LV, Evangelista LS et al (2009) A comparative study of pain in heart failure and non-heart failure veterans. J Card Fail 15:24–30
63. Goodlin SJ, Wingate S, Albert NM et al (2012) Investigating pain in heart failure patients: the pain assessment, incidence, and nature in heart failure (PAIN-HF) study. J Card Fail 18:776–783
64. Ballantyne JC, Sullivan MD (2015) Intensity of chronic pain-the wrong metric? N Engl J Med 373:2098–2099
65. Ferrell BR, Coyle N (2008) The nature of suffering and the goals of nursing. Oncol Nurs Forum 35:241–247
66. Udeoji DU, Shah AB, Bharadwaj P, Katsiyiannis P, Schwarz ER (2012) Evaluation of the prevalence and severity of pain in patients with stable chronic heart failure. World J Cardiol 4:250–255
67. Godfrey C, Harrison MB, Medves J, Tranmer JE (2006) The symptom of pain with heart failure: a systematic review. J Card Fail 12:307–313
68. Gureje O, Von Korff M, Simon GE, Gater R (1998) Persistent pain and well-being: a World Health Organization study in primary care. JAMA 280:147–151
69. Evangelista LS, Berg J, Dracup K (2001) Relationship between psychosocial variables and compliance in patients with heart failure. Heart Lung 30:294–301
70. McCaffery M, Pasero C (1999) Pain: clinical manual, 2nd edn. Mosby, St. Louis
71. Light-McGroary K, Goodlin SJ (2013) The challenges of understanding and managing pain in the heart failure patient. Curr Opin Support Palliat Care 7:14–20
72. Adler ED, Goldfinger JZ, Kalman J, Park ME, Meier DE (2009) Palliative care in the treatment of advanced heart failure. Circulation 120:2597–2606
73. WHO Pain Relief Ladder. http://www.who.int/cancer/palliative/painladder/en/
74. Lee H, Schmidt K, Ernst E (2005) Acupuncture for the relief of cancer-related pain–a systematic review. Eur J Pain 9:437–444
75. Knols R, Aaronson NK, Uebelhart D, Fransen J, Aufdemkampe G (2005) Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 23:3830–3842
76. Cepeda MS, Carr DB, Lau J, Alvarez H (2006) Music for pain relief. Cochrane Database Syst Rev 2:CD004843
77. Feenstra J, Heerdink ER, Grobbee DE, Stricker BH (2002) Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med 162:265–270
78. Page J, Henry D (2000) Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 160:777–784
79. Merriam SA, Claxton R. Fast facts and concepts #249: topical nonsteroidal anti-inflammatory drugs. Palliative Care Network of Wisconsin. http://www.mypcnow.org/#!blank/y675m
80. Gimbel J, Linn R, Hale M, Nicholson B (2005) Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study. Am J Ther 12:311–319
81. Addington-Hall JM, Rogers A, McCoy A, Gibbs J (2003) Heart disease. In: Morrison RS, Meier DE, Capello C (eds) Geriatric palliative care. Oxford University Press, New York
82. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ (2006) Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 48:1527–1537
83. Park SH, Wackernah RC, Stimmel GL (2014) Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants? J Pharm Pract 27:71–78
84. Connor SR, Pyenson B, Fitch K, Spence C, Iwasaki K (2007) Comparing hospice and nonhospice patient survival among patients who die within a three-year window. J Pain Symptom Manag 33:238–246
85. Chen A, Ashburn MA (2015) Cardiac effects of opioid therapy. Pain Med 16(Suppl 1):S27–S31
86. Morita T, Tsunoda J, Inoue S, Chihara S (2001) Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manag 21:282–289
87. Chan JD, Treece PD, Engelberg RA et al (2004) Narcotic and benzodiazepine use after withdrawal of life support: association with time to death? Chest 126:286–293
88. (1999) Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 159:321–340
89. Mann DL (2011) Heart failure: a companion to Braunwald’s heart disease, 2nd edn. Saunders, Philadelphia
90. Edmonds PM, Rogers A, Addington-Hall JM, McCoy A, Coats AJ, Gibbs JS (2005) Patient descriptions of breathlessness in heart failure. Int J Cardiol 98:61–66
91. Wilcock A, Crosby V, Hughes A, Fielding K, Corcoran R, Tattersfield AE (2002) Descriptors of breathlessness in patients with cancer and other cardiorespiratory diseases. J Pain Symptom Manag 23:182–189
92. West RL, Hernandez AF, O’Connor CM, Starling RC, Califf RM (2010) A review of dyspnea in acute heart failure syndromes. Am Heart J 160:209–214
93. Lip G, Zarifis J, Beevers DG (1997) Acute admissions with heart failure to a district general hospital serving a multiracial population. Int J Clin Pract 51:223–227
94. Tataryn D, Chochinov HM (2002) Predicting the trajectory of will to live in terminally ill patients. Psychosomatics 43:370–377
95. Reddy SK, Parsons HA, Elsayem A, Palmer JL, Bruera E (2009) Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med 12:29–36
96. Simon ST, Higginson IJ, Benalia H et al (2013) Episodic and continuous breathlessness: a new categorization of breathlessness. J Pain Symptom Manag 45:1019–1029
97. Ezekowitz JA, Hernandez AF, O’Connor CM et al (2012) Assessment of dyspnea in acute decompensated heart failure: insights from ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) on the contributions of peak expiratory flow. J Am Coll Cardiol 59:1441–1448
98. Pang PS, Cleland JG, Teerlink JR et al (2008) A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J 29:816–824
99. Witte KK, Clark AL (2007) Why does chronic heart failure cause breathlessness and fatigue? Prog Cardiovasc Dis 49:366–384
100. Gift AG, Narsavage G (1998) Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care 7:200–204
101. Wysham NG, Miriovsky BJ, Currow DC et al (2015) Practical dyspnea assessment: relationship between the 0–10 numerical rating scale and the four-level Categorical Verbal Descriptor Scale of dyspnea intensity. J Pain Symptom Manag 50:480–487
102. Higginson IJ, Bausewein C, Reilly CC et al (2014) An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med 2:979–987
103. von Haehling S, Lainscak M, Springer J, Anker SD (2009) Cardiac cachexia: a systematic overview. Pharmacol Ther 121:227–252
104. Adamopoulos S, Schmid JP, Dendale P et al (2014) Combined aerobic/inspiratory muscle training vs. aerobic training in patients with chronic heart failure: the Vent-HeFT trial: a European prospective multicentre randomized trial. Eur J Heart Fail 16:574–582
105. Currow DC, Abernethy AP (2007) Pharmacological management of dyspnoea. Curr Opin Support Palliat Care 1:96–101
106. Higginson IJ (2010) Refractory breathlessness: oxygen or room air? Lancet 376:746–748
107. Abernethy AP, McDonald CF, Frith PA et al (2010) Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet 376:784–793
108. Booth S, Wade R, Johnson M et al (2004) The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 98:66–77
109. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C (2003) Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 327:523–528
110. Thomas JR, von Gunten CF (2002) Clinical management of dyspnoea. Lancet Oncol 3:223–228
111. Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C (2010) Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 20(1):CD007354
112. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S (2010) Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manag 39:831–838
113. Dy SM, Apostol CC (2010) Evidence-based approaches to other symptoms in advanced cancer. Cancer J 16:507–513
114. Bausewein C, Booth S, Gysels M, Higginson I (2008) Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 16(2):CD005623
115. Pozehl B, Duncan K, Hertzog M (2008) The effects of exercise training on fatigue and dyspnea in heart failure. Eur J Cardiovasc Nurs 7:127–132
116. Pittler MH, Guo R, Ernst E (2008) Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev 23(1):CD005312
117. Bredin M, Corner J, Krishnasamy M, Plant H, Bailey C, A’Hern R (1999) Multicentre randomised controlled trial of nursing intervention for breathlessness in patients with lung cancer. BMJ 318:901–904
118. Cahalin LP, Arena RA (2015) Breathing exercises and inspiratory muscle training in heart failure. Heart Fail Clin 11:149–172
119. Bausewein C, Jolley C, Reilly C et al (2012) Development, effectiveness and cost-effectiveness of a new out-patient Breathlessness Support Service: study protocol of a phase III fast-track randomised controlled trial. BMC Pulm Med 12:58
120. Holzapfel N, Muller-Tasch T, Wild B et al (2008) Depression profile in patients with and without chronic heart failure. J Affect Disord 105:53–62
121. Faris R, Purcell H, Henein MY, Coats AJ (2002) Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 4:541–551
122. Rumsfeld JS, Havranek E, Masoudi FA et al (2003) Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 42:1811–1817
123. Murberg TA, Bru E, Svebak S, Tveteras R, Aarsland T (1999) Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study. Int J Psychiatry Med 29:311–326
124. Sullivan M, Simon G, Spertus J, Russo J (2002) Depression-related costs in heart failure care. Arch Intern Med 162:1860–1866
125. Carels RA, Musher-Eizenman D, Cacciapaglia H, Perez-Benitez CI, Christie S, O’Brien W (2004) Psychosocial functioning and physical symptoms in heart failure patients: a within-individual approach. J Psychosom Res 56:95–101
126. Muller-Tasch T, Peters-Klimm F, Schellberg D et al (2007) Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice. J Card Fail 13:818–824
127. Jiang W, Alexander J, Christopher E et al (2001) Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 161:1849–1856
128. Brauser D (2015) OPERA HF: moderate, severe depression may independently increase mortality risk in Heart Failure Patients. Medscape. http://www.medscape.com/viewarticle/845340
129. Lowey SE, Norton SA, Quinn JR, Quill TE (2013) Living with advanced heart failure or COPD: experiences and goals of individuals nearing the end of life. Res Nurs Health 36:349–358
130. Herman JG (1987) New oxygen delivery systems. Gaining patient compliance. Respir Manag 17(30–9):64
131. Logan PA, Dyas J, Gladman JR (2004) Using an interview study of transport use by people who have had a stroke to inform rehabilitation. Clin Rehabil 18:703–708
132. Sears SF, Hauf JD, Kirian K, Hazelton G, Conti JB (2011) Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. Circ Arrhythm Electrophysiol 4:242–250
133. Kroenke K, Spitzer RL, Williams JB (2003) The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care 41:1284–1292
134. Greco T, Eckert G, Kroenke K (2004) The outcome of physical symptoms with treatment of depression. J Gen Intern Med 19:813–818
135. O’Connor CM, Jiang W, Kuchibhatla M et al (2010) Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol 56:692–699
136. Reynolds CF 3rd, Dew MA, Pollock BG et al (2006) Maintenance treatment of major depression in old age. N Engl J Med 354:1130–1138
137. Angermann CE, Gelbrich G, Stork S et al (2016) Effect of escitalopram on all-cause mortality and hospitalization in patients with heart failure and depression: the MOOD-HF randomized clinical trial. JAMA 315:2683–2693
138. Jacob S, Spinler SA (2006) Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults. Ann Pharmacother 40:1618–1622
139. Funk KA, Bostwick JR (2013) A comparison of the risk of QT prolongation among SSRIs. Ann Pharmacother 47:1330–1341
140. Marken PA, Munro JS (2000) Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features. Prim Care Companion J Clin Psychiatry 2:205–210
141. Colucci VJ, Berry BD (2008) Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy. Ann Pharmacother 42:882–887
142. Harris J, Heil JS (2013) Managing depression in patients with advanced heart failure awaiting transplantation. Am J Health Syst Pharm 70:867–873
143. Qaseem A, Barry MJ, Kansagara D (2016) Clinical Guidelines Committee of the American College of P. Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: a clinical practice guideline from the American College of Physicians. Ann Intern Med 164:350–359
144. O’Connor CM, Joynt KE (2004) Depression: are we ignoring an important comorbidity in heart failure? J Am Coll Cardiol 43:1550–1552
145. Reisfield G, Wilson G. Fast facts and concepts #144: palliative care issues in heart failure Palliative Care Network of Wisconsin. http://www.mypcnow.org/blank-fmfev
146. Lundgren J, Andersson G, Johansson P (2015) Can cognitive behaviour therapy be beneficial for heart failure patients? Curr Heart Fail Rep 12:166–172
147. Bekelman DB, Dy SM, Becker DM et al (2007) Spiritual well-being and depression in patients with heart failure. J Gen Intern Med 22:470–477
148. Sullivan MJ, Wood L, Terry J et al (2009) The support, education, and research in chronic heart failure study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J 157:84–90
149. Lane DA, Chong AY, Lip GY (2005) Psychological interventions for depression in heart failure. Cochrane Database Syst Rev 25(1):CD003329
150. Goodlin SJ, Hauptman PJ, Arnold R et al (2004) Consensus statement: palliative and supportive care in advanced heart failure. J Card Fail 10:200–209
151. Stevenson LW, O’Donnell A (2015) Advanced care planning: care to plan in advance. JACC Heart Fail 3:122–126
152. Kirkpatrick JN, Gottlieb M, Sehgal P, Patel R, Verdino RJ (2012) Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care. Am J Cardiol 109:91–94
153. Bekelman DB, Plomondon ME, Carey EP et al (2015) Primary results of the patient-centered disease management (PCDM) for heart failure study: a randomized clinical trial. JAMA Intern Med 175:725–732
154. Gavazzi A, De Maria R, Manzoli L et al (2015) Palliative needs for heart failure or chronic obstructive pulmonary disease: results of a multicenter observational registry. Int J Cardiol 184:552–558
155. Sandek A, Swidsinski A, Schroedl W et al (2014) Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia. J Am Coll Cardiol 64:1092–1102
156. Halpin A, Huckabay LM, Kozuki JL, Forsythe D (2010) Weigh the benefits of using a 0-to-5 nausea scale. Nursing 40:18–20
157. Meiri E, Jhangiani H, Vredenburgh JJ et al (2007) Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting. Curr Med Res Opin 23:533–543
158. Glare P, Miller J, Nikolova T, Tickoo R (2011) Treating nausea and vomiting in palliative care: a review. Clin Interv Aging 6:243–259
159. Coffin B, Causse C (2011) Constipation assessment scales in adults: a literature review including the new Bowel Function Index. Expert Rev Gastroenterol Hepatol 5:601–613
160. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L (2013) American College of G. Clinical guideline: management of gastroparesis. Am J Gastroenterol 108:18–37 (quiz 38)
161. Nguyen NQ, Yi Mei SL (2011) Current issues on safety of prokinetics in critically ill patients with feed intolerance. Ther Adv Drug Saf 2:197–204
162. Waseem S, Moshiree B, Draganov PV (2009) Gastroparesis: current diagnostic challenges and management considerations. World J Gastroenterol 15:25–37
163. Stimmel GL, Dopheide JA, Stahl SM (1997) Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects. Pharmacotherapy 17:10–21
164. Beal JE, Olson R, Lefkowitz L et al (1997) Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. J Pain Symptom Manag 14:7–14
165. Thomas DR (2004) Incidence of venous thromboembolism in megestrol acetate users. J Am Med Dir Assoc 5:65–66 (author reply 66–67)
166. Doehner W, Frenneaux M, Anker SD (2014) Metabolic impairment in heart failure: the myocardial and systemic perspective. J Am Coll Cardiol 64:1388–1400
167. Kohnlein T, Welte T, Tan LB, Elliott MW (2002) Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax 57:547–554
168. Shah AB, Morrissey RP, Baraghoush A et al (2013) Failing the failing heart: a review of palliative care in heart failure. Rev Cardiovasc Med 14:41–48
169. Falk K, Patel H, Swedberg K, Ekman I (2009) Fatigue in patients with chronic heart failure—a burden associated with emotional and symptom distress. Eur J Cardiovasc Nurs 8:91–96
170. Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT (2004) Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169:361–366
171. Lennie TA, Moser DK, Biddle MJ et al (2013) Nutrition intervention to decrease symptoms in patients with advanced heart failure. Res Nurs Health 36:120–145
172. Toyama T, Seki R, Kasama S et al (2009) Effectiveness of nocturnal home oxygen therapy to improve exercise capacity, cardiac function and cardiac sympathetic nerve activity in patients with chronic heart failure and central sleep apnea. Circ J 73:299–304
173. Nymark TB, Hovland A, Bjornstad H, Nielsen EW (2008) A young man with acute dilated cardiomyopathy associated with methylphenidate. Vasc Health Risk Manag 4:477–479
174. Come CE, Shapiro PA (2005) Supraventricular tachycardia associated with methylphenidate treatment in a heart transplant recipient. Psychosomatics 46:461–463
175. Thompson J, Thompson JR (2010) Acute myocardial infarction related to methylphenidate for adult attention deficit disorder. J Emerg Med 38:18–21
176. Schelleman H, Bilker WB, Kimmel SE et al (2012) Methylphenidate and risk of serious cardiovascular events in adults. Am J Psychiatry 169:178–185
177. Pharmaceuticals J. Package insert: CONCERTA. 2000 (revised 12/2013)
178. Dzida G, Prystupa A, Lachowska-Kotowska P et al (2013) Alteration in diurnal and nocturnal melatonin serum level in patients with chronic heart failure. Ann Agric Environ Med 20:745–748
179. Abete P, Bianco S, Calabrese C et al (1997) Effects of melatonin in isolated rat papillary muscle. FEBS Lett 412:79–85
180. Khan RF, Feder S, Goldstein NE, Chaudhry SI (2015) Symptom burden among patients who were hospitalized for heart failure. JAMA Intern Med 175:1713–1715
181. Desbiens NA, Wu AW, Alzola C et al (1997) Pain during hospitalization is associated with continued pain six months later in survivors of serious illness. The SUPPORT investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. Am J Med 102:269–276
182. Pantilat SZ, O’Riordan DL, Dibble SL, Landefeld CS (2012) Longitudinal assessment of symptom severity among hospitalized elders diagnosed with cancer, heart failure, and chronic obstructive pulmonary disease. J Hosp Med 7:567–572
183. Hauptman PJ, Havranek EP (2005) Integrating palliative care into heart failure care. Arch Intern Med 165:374–378
184. Casarett D, Pickard A, Bailey FA et al (2008) Do palliative consultations improve patient outcomes? J Am Geriatr Soc 56:593–599
185. Pirl WF, Greer JA, Traeger L et al (2012) Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol 30:1310–1315
186. Sidebottom AC, Jorgenson A, Richards H, Kirven J, Sillah A (2015) Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial. J Palliat Med 18:134–142
187. Evangelista LS, Liao S, Motie M, De Michelis N, Ballard-Hernandez J, Lombardo D (2014) Does the type and frequency of palliative care services received by patients with advanced heart failure impact symptom burden? J Palliat Med 17:75–79
188. Rutten FH, Heddema WS, Daggelders GJ, Hoes AW (2012) Primary care patients with heart failure in the last year of their life. Fam Pract 29:36–42
189. Mentz RJ, Tulsky JA, Granger BB et al (2014) The palliative care in heart failure trial: rationale and design. Am Heart J 168(645–651):e1
190. Riegel B, Moser DK, Powell M, Rector TS, Havranek EP (2006) Nonpharmacologic care by heart failure experts. J Card Fail 12:149–153
191. Kavalieratos D, Mitchell EM, Carey TS et al (2014) “Not the ‘grim reaper service’”: an assessment of provider knowledge, attitudes, and perceptions regarding palliative care referral barriers in heart failure. J Am Heart Assoc 3:e000544
192. Kamal AH, Maguire JM, Meier DE (2015) Evolving the palliative care workforce to provide responsive, serious illness care. Ann Intern Med 163:637–638
193. Kamal AH, Bull J, Wolf S et al (2016) Characterizing the hospice and palliative care workforce in the U.S.: clinician demographics and professional responsibilities. J Pain Symptom Manag 51:597–603
194. Quill TE, Abernethy AP (2013) Generalist plus specialist palliative care–creating a more sustainable model. N Engl J Med 368:1173–1175
195. Whellan DJ, Goodlin SJ, Dickinson MG et al (2014) End-of-life care in patients with heart failure. J Card Fail 20:121–134
196. Kelley AS, Morrison RS (2015) Palliative care for the seriously ill. N Engl J Med 373:747–755
197. Dev S, Abernethy AP, Rogers JG, O’Connor CM (2012) Preferences of people with advanced heart failure-a structured narrative literature review to inform decision making in the palliative care setting. Am Heart J 164(313–319):e5
198. Munoz-Mendoza J (2015) Competencies in palliative care for cardiology fellows. J Am Coll Cardiol 65:750–752
199. Howlett J, Morin L, Fortin M et al (2010) End-of-life planning in heart failure: it should be the end of the beginning. Can J Cardiol 26:135–141
200. Fallowfield LJ (2000) How to improve the communication skills of oncologists. Ann Oncol 11(Suppl 3):63–66
201. Butler J, Binney Z, Kalogeropoulos A et al (2015) Advance directives among hospitalized patients with heart failure. JACC Heart Fail 3:112–121